Herman F. Staats

Publications

• Novel Mucosal Adjuvant, Mastoparan-7, Improves Cocaine Vaccine Efficacy
  NPJ Vaccines. Feb, 2020  |   Pubmed ID: 33536438
• Novel Mucosal Adjuvant, Mastoparan-7, Improves Cocaine Vaccine Efficacy
  NPJ Vaccines. 2020  |   Pubmed ID: 32047657
• Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble Gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen
  Journal of Virology. 07, 2019  |   Pubmed ID: 31068425
• Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening
  SLAS Discovery : Advancing Life Sciences R & D. 07, 2019  |   Pubmed ID: 30917061
• Nasal Peanut+ CpG Immunotherapy Enhances Peanut-specific IFN-γ in Th2 Cells and IL-10 in Non-Th2 Cells in Mice
  Allergy. 11, 2019  |   Pubmed ID: 30746720
• Softness Makes It Better
  Nature Materials. Feb, 2018  |   Pubmed ID: 31745266
• Perivascular Dendritic Cells Elicit Anaphylaxis by Relaying Allergens to Mast Cells Via Microvesicles
  Science (New York, N.Y.). 11, 2018  |   Pubmed ID: 30409859
• Mast Cell Activators As Novel Immune Regulators
  Current Opinion in Pharmacology. 08, 2018  |   Pubmed ID: 29843056
• Vaccine Adjuvants: Softness Makes It Better
  Nature Materials. 01, 2018  |   Pubmed ID: 29358771
• Effect of Endotoxin and Alum Adjuvant Vaccine on Peanut Allergy
  The Journal of Allergy and Clinical Immunology. 02, 2018  |   Pubmed ID: 28927819
• Assessing the Satisfaction and Burden Within an Academic Animal Care and Use Program
  FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 09, 2017  |   Pubmed ID: 28515151
• Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection Against Nasal Rabbitpox Virus Challenge
  Clinical and Vaccine Immunology : CVI. 07, 2016  |   Pubmed ID: 27146001
• Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk
  Journal of Virology. May, 2016  |   Pubmed ID: 26937027
• Immunization with the Haemophilus Ducreyi Trimeric Autotransporter Adhesin DsrA with Alum, CpG or Imiquimod Generates a Persistent Humoral Immune Response That Recognizes the Bacterial Surface
  Vaccine. Feb, 2016  |   Pubmed ID: 26812077
• Intranasal MRNA Nanoparticle Vaccination Induces Prophylactic and Therapeutic Anti-tumor Immunity
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Sep, 2015  |   Pubmed ID: 27005208
• Serological Response Following Re-vaccination with Salmonella Typhi Vi-capsular Polysaccharide Vaccines in Healthy Adult Travellers
  Vaccine. Aug, 2015  |   Pubmed ID: 26144902
• Effect of Particulate Adjuvant on the Anthrax Protective Antigen Dose Required for Effective Nasal Vaccination
  Vaccine. Jul, 2015  |   Pubmed ID: 26087299
• Intranasal MRNA Nanoparticle Vaccination Induces Prophylactic and Therapeutic Anti-tumor Immunity
  Scientific Reports. Jun, 2014  |   Pubmed ID: 24894817
• Which Comes First: the Antigen or the Adjuvant?
  The Journal of Clinical Investigation. Jun, 2014  |   Pubmed ID: 24837429
• Salmonella Typhimurium Impedes Innate Immunity with a Mast-cell-suppressing Protein Tyrosine Phosphatase, SptP
  Immunity. Dec, 2013  |   Pubmed ID: 24332031
• A Mastoparan-derived Peptide Has Broad-spectrum Antiviral Activity Against Enveloped Viruses
  Peptides. Oct, 2013  |   Pubmed ID: 23891650
• A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents
  MedChemComm. Jan, 2013  |   Pubmed ID: 23667736
• Mucosal Immunization of Lactating Female Rhesus Monkeys with a Transmitted/founder HIV-1 Envelope Induces Strong Env-specific IgA Antibody Responses in Breast Milk
  Journal of Virology. Jun, 2013  |   Pubmed ID: 23596289
• Evaluation of Vaccine-induced Antibody Responses: Impact of New Technologies
  Vaccine. Jun, 2013  |   Pubmed ID: 23583812
• A Comparison of Non-toxin Vaccine Adjuvants for Their Ability to Enhance the Immunogenicity of Nasally-administered Anthrax Recombinant Protective Antigen
  Vaccine. Mar, 2013  |   Pubmed ID: 23352329
• Maximal Adjuvant Activity of Nasally Delivered IL-1α Requires Adjuvant-responsive CD11c(+) Cells and Does Not Correlate with Adjuvant-induced in Vivo Cytokine Production
  Journal of Immunology (Baltimore, Md. : 1950). Mar, 2012  |   Pubmed ID: 22345651
• Synthetic Mast-cell Granules As Adjuvants to Promote and Polarize Immunity in Lymph Nodes
  Nature Materials. Jan, 2012  |   Pubmed ID: 22266469
• Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine
  Journal of Pharmaceutical Sciences. Jan, 2012  |   Pubmed ID: 21905034
• Cytokines: the Future of Intranasal Vaccine Adjuvants
  Clinical & Developmental Immunology. 2011  |   Pubmed ID: 21826181
• Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits
  PloS One. Jan, 2011  |   Pubmed ID: 21304600
• Scarcity or Absence of Humoral Immune Responses in the Plasma and Cervicovaginal Lavage Fluids of Heavily HIV-1-exposed but Persistently Seronegative Women
  AIDS Research and Human Retroviruses. May, 2011  |   Pubmed ID: 21091128
• Effective Induction of Protective Systemic Immunity with Nasally Administered Vaccines Adjuvanted with IL-1
  Vaccine. Oct, 2010  |   Pubmed ID: 20723629
• Adenovirus F Protein As a Delivery Vehicle for Botulinum B
  BMC Immunology. Jul, 2010  |   Pubmed ID: 20609248
• Development of a Bead Immunoassay to Measure Vi Polysaccharide-specific Serum IgG After Vaccination with the Salmonella Enterica Serovar Typhi Vi Polysaccharide
  Clinical and Vaccine Immunology : CVI. Mar, 2010  |   Pubmed ID: 20107010
• Mast Cells Augment Adaptive Immunity by Orchestrating Dendritic Cell Trafficking Through Infected Tissues
  Cell Host & Microbe. Oct, 2009  |   Pubmed ID: 19837373
• Mast Cell-derived Particles Deliver Peripheral Signals to Remote Lymph Nodes
  The Journal of Experimental Medicine. Oct, 2009  |   Pubmed ID: 19808250
• The Mast Cell Activator Compound 48/80 is Safe and Effective when Used As an Adjuvant for Intradermal Immunization with Bacillus Anthracis Protective Antigen
  Vaccine. Jun, 2009  |   Pubmed ID: 19464533
• Identification of Recombinant Antibodies Against Multiple Distinct Toll-like Receptors by Homolog Mining a Single Immune ScFv Phage Library
  Journal of Immunological Methods. Jan, 2009  |   Pubmed ID: 19017532
• The Contribution of Type I Interferon Signaling to Immunity Induced by Alphavirus Replicon Vaccines
  Vaccine. Sep, 2008  |   Pubmed ID: 18656518
• Alphavirus Replicon Particles Acting As Adjuvants Promote CD8+ T Cell Responses to Co-delivered Antigen
  Vaccine. Aug, 2008  |   Pubmed ID: 18582997
• Nonmucosal Alphavirus Vaccination Stimulates a Mucosal Inductive Environment in the Peripheral Draining Lymph Node
  Journal of Immunology (Baltimore, Md. : 1950). Jul, 2008  |   Pubmed ID: 18566424
• An Entirely Cell-based System to Generate Single-chain Antibodies Against Cell Surface Receptors
  Journal of Molecular Biology. May, 2008  |   Pubmed ID: 18455737
• Mast Cell Activators: a New Class of Highly Effective Vaccine Adjuvants
  Nature Medicine. May, 2008  |   Pubmed ID: 18425129
• In Vitro and in Vivo Characterization of Anthrax Anti-protective Antigen and Anti-lethal Factor Monoclonal Antibodies After Passive Transfer in a Mouse Lethal Toxin Challenge Model to Define Correlates of Immunity
  Infection and Immunity. Nov, 2007  |   Pubmed ID: 17709410
• Transdermal Therapeutic System of Carvedilol: Effect of Hydrophilic and Hydrophobic Matrix on in Vitro and in Vivo Characteristics
  AAPS PharmSciTech. Jan, 2007  |   Pubmed ID: 17408218
• Oral Immunogenicity of the Plant Proteinase Bromelain
  International Immunopharmacology. Dec, 2006  |   Pubmed ID: 17161360
• Generation of Mucosal Anti-human Immunodeficiency Virus Type 1 T-cell Responses by Recombinant Mycobacterium Smegmatis
  Clinical and Vaccine Immunology : CVI. Nov, 2006  |   Pubmed ID: 16943347
• Capric Acid and Hydroxypropylmethylcellulose Increase the Immunogenicity of Nasally Administered Peptide Vaccines
  AIDS Research and Human Retroviruses. Jun, 2006  |   Pubmed ID: 16796531
• Mucosal and Systemic Adjuvant Activity of Alphavirus Replicon Particles
  Proceedings of the National Academy of Sciences of the United States of America. Mar, 2006  |   Pubmed ID: 16505353
• Nasal Peptide Vaccination Elicits CD8 Responses and Reduces Viral Burden After Challenge with Virulent Murine Cytomegalovirus
  Microbiology and Immunology. 2005  |   Pubmed ID: 15722596
• Gender Differences in Human Immunodeficiency Virus Type 1-specific CD8 Responses in the Reproductive Tract and Colon Following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting
  Journal of Virology. Dec, 2004  |   Pubmed ID: 15542668
• Mast Cell-derived Tumor Necrosis Factor Induces Hypertrophy of Draining Lymph Nodes During Infection
  Nature Immunology. Dec, 2003  |   Pubmed ID: 14595438
• Prolonged CD4+ Cell/virus Load Discordance During Treatment with Protease Inhibitor-based Highly Active Antiretroviral Therapy: Immune Response and Viral Control
  The Journal of Infectious Diseases. Apr, 2003  |   Pubmed ID: 12660916
• Increased Immunogenicity of HIV Envelope Subunit Complexed with Alpha2-macroglobulin when Combined with Monophosphoryl Lipid A and GM-CSF
  Vaccine. May, 2002  |   Pubmed ID: 12009296
• Cytokines As Adjuvants for the Induction of Anti-human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions After Nasal Immunization
  Journal of Virology. Jan, 2002  |   Pubmed ID: 11752142